Sara Nochur - Dec 3, 2021 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director
Signature
/s/ Elisabeth Leiderman, Attorney-in-Fact
Stock symbol
DBTX
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/6/2021, 03:19 PM
Next filing
Feb 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +20K $0.00 20K Dec 3, 2021 Common Stock 20K $6.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on December 3, 2021 for 20,000 shares. The shares underlying the option vest in equal monthly installments until the third anniversary of the grant date, subject to the reporting person's continued service.